1. Home
  2. JMM vs SER Comparison

JMM vs SER Comparison

Compare JMM & SER Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • JMM
  • SER
  • Stock Information
  • Founded
  • JMM 1988
  • SER 2017
  • Country
  • JMM United States
  • SER United States
  • Employees
  • JMM N/A
  • SER N/A
  • Industry
  • JMM Trusts Except Educational Religious and Charitable
  • SER Biotechnology: Pharmaceutical Preparations
  • Sector
  • JMM Finance
  • SER Health Care
  • Exchange
  • JMM Nasdaq
  • SER Nasdaq
  • Market Cap
  • JMM 59.8M
  • SER 55.2M
  • IPO Year
  • JMM N/A
  • SER 2018
  • Fundamental
  • Price
  • JMM $6.23
  • SER $4.92
  • Analyst Decision
  • JMM
  • SER Strong Buy
  • Analyst Count
  • JMM 0
  • SER 2
  • Target Price
  • JMM N/A
  • SER $13.00
  • AVG Volume (30 Days)
  • JMM 16.1K
  • SER 37.0K
  • Earning Date
  • JMM 01-01-0001
  • SER 11-11-2025
  • Dividend Yield
  • JMM 5.44%
  • SER N/A
  • EPS Growth
  • JMM N/A
  • SER N/A
  • EPS
  • JMM N/A
  • SER N/A
  • Revenue
  • JMM N/A
  • SER $130,000.00
  • Revenue This Year
  • JMM N/A
  • SER $134.46
  • Revenue Next Year
  • JMM N/A
  • SER N/A
  • P/E Ratio
  • JMM N/A
  • SER N/A
  • Revenue Growth
  • JMM N/A
  • SER N/A
  • 52 Week Low
  • JMM $5.29
  • SER $3.81
  • 52 Week High
  • JMM $6.10
  • SER $8.05
  • Technical
  • Relative Strength Index (RSI)
  • JMM 43.55
  • SER 45.09
  • Support Level
  • JMM $6.23
  • SER $4.76
  • Resistance Level
  • JMM $6.38
  • SER $5.23
  • Average True Range (ATR)
  • JMM 0.07
  • SER 0.24
  • MACD
  • JMM -0.01
  • SER -0.04
  • Stochastic Oscillator
  • JMM 21.54
  • SER 17.75

About JMM Nuveen Multi-Market Income Fund (MA)

Nuveen Multi-Market Income Fund is a United States-based closed-end management investment company. The investment objective of the company is to provide high monthly income consistent with prudent risk to capital. The fund predominantly invests in debt securities including, but not limited to residential and commercial mortgage-backed securities, asset-backed securities, corporate debt obligations, convertible debt securities, U.S. government securities, and other such fixed income instruments. It may also invest in preferred stocks.

About SER Serina Therapeutics Inc.

Serina Therapeutics Inc is a clinical-stage biotechnology company developing a pipeline of wholly-owned drug product candidates to treat neurological diseases and pain. Serina's POZ Platform delivery technology is engineered to provide control in drug loading and more precision in the rate of release of attached drugs, enabling the potential of certain challenging small molecules, while addressing the limitations of polyethylene glycol (PEG) and other biocompatible polymers. The Company has one reportable segment relating to the research and development of its POZ platform.

Share on Social Networks: